Equities

Farmacias Benavides SAB de CV

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Farmacias Benavides SAB de CV

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (MXN)26.00
  • Today's Change0.00 / 0.00%
  • Shares traded11.00
  • 1 Year change+13.04%
  • Beta--
Data delayed at least 20 minutes, as of Oct 29 2025 18:42 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.

  • Revenue in MXN (TTM)18.40bn
  • Net income in MXN228.54m
  • Incorporated1992
  • Employees7.91k
  • Location
    Farmacias Benavides SAB de CVAv. Fundadores No. 935Int. 301, Col. Valle del MiradorMONTERREY 64750MexicoMEX
  • Phone+52 8 181260000
  • Fax+52 8 183899931
  • Websitehttps://www.benavides.com.mx/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.